There is growing evidence that blood pressure (BP) monitoring and home BP monitoring are useful for predicting hypertensive target organ damage and the risk of cardio-and cerebrovascular events. Ambulatory BP monitoring and home BP monitoring have been reported to be better predictors than clinic BP in many population studies. In a recent issue of Hypertension, Hara et al showed that ambulatory BP, especially nighttime BP, was better correlated with silent cerebrovascular disease than home BP and that home BP was better associated with carotid atherosclerosis than ambulatory BP. 1 However, they also found that clinic BP was not a good predictor of these measures of target organ damage.
